By G HossainPosted on October 1, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs After a frantic second quarter, M&A steadied with just under $30 billion across 22 total transactions, according to a BioSpace analysis. M&A slows in Q3 but Vertex snags one of the year’s biggest in $10B Crinetics buy Post navigation The race for access: How the FAIR Act could reclaim U.S. biotech leadershipSanofi pays Regeneron $1B upfront to continue search for Dupixent successor
